Sassa S
Rockefeller University, New York, NY 10021.
Int J Cell Cloning. 1990 Jan;8(1):10-26. doi: 10.1002/stem.5530080104.
There are eight enzymes in the heme biosynthetic pathway and three enzymes in the heme catabolic pathway. Enzymatic defects in heme biosynthesis lead to clinical conditions termed porphyrias. cDNAs for five of the eight enzymes in the heme biosynthetic pathway and two of the three enzymes in the heme catabolic pathway have been cloned and characterized in mammalian cells. At least two enzymes exist as isozymes between erythroid and non-erythroid tissues. One is delta-aminolevulinic acid synthase (ALAS), and the erythroid and hepatic isozymes are coded by two separate genes. The other is porphobilinogen deaminase (PBGD), and both the erythroid and the non-erythroid PBGD mRNA are transcribed from a single PBGD gene by alternate transcription and splicing. There is also a significant tissue-specific control of expression of the uroporphyrinogen decarboxylase gene which is expressed as a unique mRNA in all tissues.
血红素生物合成途径中有八种酶,血红素分解代谢途径中有三种酶。血红素生物合成过程中的酶缺陷会导致临床上称为卟啉症的病症。血红素生物合成途径中八种酶中的五种以及血红素分解代谢途径中三种酶中的两种的cDNA已在哺乳动物细胞中克隆并进行了表征。至少有两种酶在红细胞和非红细胞组织中以同工酶形式存在。一种是δ-氨基乙酰丙酸合酶(ALAS),红细胞和肝脏中的同工酶由两个不同的基因编码。另一种是胆色素原脱氨酶(PBGD),红细胞和非红细胞的PBGD mRNA均通过交替转录和剪接从单个PBGD基因转录而来。尿卟啉原脱羧酶基因的表达也存在显著的组织特异性调控,该基因在所有组织中均以独特的mRNA形式表达。